Announcement of the result of tender procedure No. 56/2020 – SARCO

OBJECT FOR THE REQUEST: Genetically modified mice with knockout expression of chitotriosidase gene (CHIT1).

After collecting all the information regarding the request for proposal and after analyzing the completeness of the offers, the Commission concludes that the most advantageous offer meeting all the requirements contained in the request has presented:

Transgenic Core Facility
Center for Inflammation Research
Ghent University – VIB
Technologiepark 71,9052 Ghent, Belgium

Total net price of the order execution: 17 000,00 EUR

The Commission recommends the Management Board to perform the order in accordance with the offer submitted by Transgenic Core Facility Center for Inflammation Research, Ghent University – VIB.

This site is registered on as a development site.